Mutational landscape and response are conserved in peripheral blood of AML and MDS patients during decitabine therapy
Author:
Affiliation:
1. Department of Pathology and Immunology,
2. Division of Oncology, Department of Internal Medicine,
3. McDonnell Genome Institute, and
4. Division of Public Health Sciences, Department of Surgery, Washington University, St. Louis, MO
Publisher
American Society of Hematology
Subject
Cell Biology,Hematology,Immunology,Biochemistry
Link
http://ashpublications.org/blood/article-pdf/129/10/1397/1399432/blood745273.pdf
Reference24 articles.
1. Implications of discrepancy in morphologic diagnosis of myelodysplastic syndrome between referral and tertiary care centers;Naqvi;Blood,2011
2. Inter-observer variance with the diagnosis of myelodysplastic syndromes (MDS) following the 2008 WHO classification;Font;Ann Hematol,2013
3. Reproducibility of the World Health Organization 2008 criteria for myelodysplastic syndromes;Senent;Haematologica,2013
4. Revised recommendations of the International Working Group for Diagnosis, Standardization of Response Criteria, Treatment Outcomes, and Reporting Standards for Therapeutic Trials in Acute Myeloid Leukemia [published correction appears in J Clin Oncol. 2004;22(3):576];Cheson;J Clin Oncol,2003
5. Bone marrow biopsy technic. Artifact induced by aspiration;Douglas;Am J Clin Pathol,1984
Cited by 26 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Correlation between peripheral blood and bone marrow mutations among patients with MDS from the National MDS Study;Blood Neoplasia;2024-09
2. Low expression of miR-182 caused by DNA hypermethylation accelerates acute lymphocyte leukemia development by targeting PBX3 and BCL2: miR-182 promoter methylation is a predictive marker for hypomethylation agents + BCL2 inhibitor venetoclax;Clinical Epigenetics;2024-03-26
3. Clinical Utility and Reimbursement of Next-Generation Sequencing–Based Testing for Myeloid Malignancies;The Journal of Molecular Diagnostics;2024-01
4. Diagnosis and classification of myelodysplastic syndromes;Blood;2023-12-28
5. How to classify risk based on clinical and molecular modeling: integrating molecular markers in the risk assessment of myelodysplastic syndrome;Hematology;2023-12-08
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3